Charity Search / ENDURE TO CURE PEDIATRIC CANCER FOUNDATION
Medical Research (H129) IRS Verified DX Registered 990 on File

ENDURE TO CURE PEDIATRIC CANCER FOUNDATION

EIN: 45-2861060 · WILMINGTON, DE 19801-1192 · United States · FY 2024 Data
3 out of 5 40 / 100 Based on 2+ years of filings
Financial strength (30%) 51/100
Reliability (20%) 50/100
Effectiveness (25%) 58/100
Impact (25%) No data yet
Financial data: FY 2024 · Scored 9/13/2026
Claim this Charity
CharityAI™ Score
Not yet evaluated
Mission Statement

Endure to Cure is a non-profit organization that raises funds to aid in the care, treatment, and research in the fight against pediatric cancer. Our mission is to advance cures for pediatric cancer, to serve as an inspiration to people worldwide, and to unite those who have been affected by cancer. This mission is carried out through our three flagship programs: Small Miracles: Customized experiences for children undergoing cancer treatment. Travel for Treatment Grant Program: Grants for families in financial need to cover immediate and uninsurable travel expenses for their child's cancer treatments. Pediatric Cancer Research Grants: Funds grants for pediatric cancer research studies to help find cures.

Financial Overview — FY 2024
$361K
Total Revenue
$395K
Total Expenses
$-46,220
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio 59.6%
Fundraising Efficiency N/A
Operating Reserve -1.40x
Liability-to-Asset 675.6%
Revenue Diversification 100.0%
Compared with Peers
FY 2024
Compared with 726 similar organizations (United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
59.6% 84.5%
P10P90
Bottom quarter
Admin expense ratio
Management and general / total expenses · lower is better
16.6% 11.4%
P10P90
Below median
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
23.8% 0.0%
P10P90
Bottom quarter
Operating reserve
Months of expenses covered by net assets · higher is better
-1.4 mo 13.4 mo
P10P90
Bottom quarter
Liabilities to assets
Total liabilities / total assets · lower is better
675.6% 0.4%
P10P90
Bottom quarter
Revenue concentration
Share of revenue from the largest source · lower is better
100.0% 93.3%
P10P90
Bottom quarter
Revenue growth
Year over year revenue growth
24.1% 9.1%
P10P90
Expense growth
Year over year expense growth
21.4% 8.8%
P10P90
Surplus margin
Surplus as a share of revenue
-9.5% 1.8%
P10P90
Financial History
Year Revenue Expenses Net Assets Program % Staff
2024 $361K $395K $-46,220 59.6% 0
2023 $291K $325K $-58,990 72.5% 0
2022 $250K $229K $-24,450 75.4% 0
2021 $158K $233K N/A — 1
2020 $141K $126K N/A — 1
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
45-2861060
State
DE
City
WILMINGTON
ZIP
19801-1192
Classification
H129
Category
Medical Research
Rating
3★
Coverage
A
Last Updated
Aug 2026
IRS Ruling Year
2011
Foundation Code
15
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search